POLR3G and urinary bladder carcinoma: These findings suggest that targeting POLR3G and its associated pathways could offer new therapeutic strategies for bladder cancer treatment, and enhance our understanding of the genetic and cellular mechanisms underlying bladder cancer progression and provide a foundation for future research aimed at elucidating the specific functions of these DEGs in bladder cancer.